Treatment-Related Adverse Events and Outcome in a Clinical Trial of Fluoxetine for Major Depressive Disorder

By Papakostas G.I.  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 15, Iss. 3-4, 2003-09 ,pp. : 187-192

Informa Healthcare

Access to resources Recommend Favorite

Anticonvulsants in the Treatment of Major Depressive Disorder: An Overview

By Vigo Daniel   Baldessarini Ross  

Harvard Review of Psychiatry, Vol. 17, Iss. 4, 2009-08 ,pp. : 231-241

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Escitalopram in the Long-term Treatment of Major Depressive Disorder

By Wade Alan   Despiegel Nicolas   Heldbo Reines Elin  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 18, Iss. 2, 2006-05 ,pp. : 83-89

Informa Healthcare

Access to resources Recommend Favorite

The bipolar diathesis of treatment-resistant major depressive disorder

By Woo Young Sup   Chae Jeong-ho   Jun Tae-youn   Kim Kwang-soo   Bahk Won-myong  

International Journal of Psychiatry in Clinical Practice, Vol. 12, Iss. 2, 2008-06 ,pp. : 142-146

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Duloxetine a new serotonin and noradrenaline reuptake inhibitor for the treatment of both major depressive disorder and female stress urinary incontinence: the implication of more than one indication for a new therapeutic agent

By Voss Simon   Gandhi Paul   Porkess Sheuli   Viktrup Lars  

Primary Care Mental Health, Vol. 3, Iss. 2, 2005-06 ,pp. : 83-92

Radcliffe Press

Access to resources Recommend Favorite